Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Hofseth Biocare ASA ( (HOFBF) ).
Hofseth BioCare ASA has successfully issued CHF-denominated unsecured bonds totaling approximately CHF 3.5 million, subscribed by investors in Switzerland and Liechtenstein. The bonds, which will mature in 2028, will support general corporate purposes, reflecting the company’s strategic financial management and potential for growth in the health sector.
More about Hofseth Biocare ASA
Hofseth BioCare ASA is a Norwegian company focused on consumer and pet health, emphasizing sustainability and the optimal use of natural resources. The company upcycles salmon industry byproducts into health-improving ingredients, such as ProGo®, OmeGo®, and CalGo®, which offer benefits ranging from improved iron metabolism to immune health and bone support. Hofseth BioCare also engages in academic partnerships and has spun out a biotech company, HBC Immunology, targeting cancer and asthma therapies.
YTD Price Performance: 55.00%
Average Trading Volume: 400
Technical Sentiment Signal: Buy
Current Market Cap: $77M
For a thorough assessment of HOFBF stock, go to TipRanks’ Stock Analysis page.